Related Experiment Videos
Hypofrontal symptoms from olanzapine: a case report.
1Department of Psychiatry, Saint Louis University School of Medicine, Missouri 63104, USA.
Summary
Olanzapine can cause severe hypofrontal symptoms, a condition not seen with older typical neuroleptics. This finding suggests dose limitations for atypical antipsychotics like olanzapine in some individuals.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Long-term exposure to typical neuroleptics can lead to neurological changes.
- Atypical antipsychotics represent a newer class of psychiatric medications.
- Hypofrontal symptoms, characterized by reduced frontal lobe function, can manifest in various neurological conditions.
Observation:
- A 31-year-old male patient experienced acute and disabling hypofrontal symptoms.
- These symptoms emerged after a prolonged 13-year period of treatment with typical neuroleptics.
- The patient had no prior history of such symptoms during typical neuroleptic treatment.
Findings:
- Olanzapine, an atypical antipsychotic, was identified as the acute inducer of these hypofrontal symptoms.
- The patient's history suggests a potential hypersensitivity or delayed reaction to atypical antipsychotics.
- This case highlights a specific adverse effect profile for olanzapine.
Implications:
- Hypofrontal symptoms may necessitate dose adjustments or discontinuation of olanzapine in susceptible patients.
- The findings suggest that milder forms of olanzapine-induced hypofrontality might be more prevalent than currently recognized.
- Further research is warranted to understand the mechanisms and prevalence of atypical antipsychotic-induced hypofrontal symptoms.